Skip to main content
logo
Amplia Therapeutics Limited (ASX:ATX)
Australia flag Australia · Delayed Price · Currency is AUD
0.1300
+0.0050 (4.00%)
Jul 31, 2026, 4:10 PM AEST

Amplia Therapeutics Financials Overview

Millions AUD. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
4.794.793.784.451.191.98
Revenue Growth
-4.32%26.63%-15.02%274.34%-40.02%29.33%
Gross Profit
4.414.413.574.010.881.83
Operating Income
-8.39-8.39-6.79-4.57-6.29-3.64
Net Income
-7.71-7.71-6.57-4.5-6.24-3.64
Earnings Per Share
-0.02-0.02-0.02-0.02-0.03-0.03
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
27.8527.8510.863.399.2614.61
Total Debt
0.340.340.011.592.282.1
Net Cash (Debt)
27.5127.5110.851.86.9812.51
Net Cash Growth
-4.39%153.59%503.17%-74.23%-44.19%576.70%
Net Cash Per Share
0.060.060.040.010.040.09

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-8.73-8.73-6.89-5.13-5.29-4.4
Capital Expenditures
-0.03-0.03-0-0-0.02-0.01
Free Cash Flow
-8.77-8.77-6.89-5.13-5.31-4.42
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
91.95%91.95%94.44%90.07%74.14%92.20%
Operating Margin
-175.09%-175.09%-179.51%-102.64%-528.45%-183.72%
Pretax Margin
-160.86%-160.86%-173.69%-101.14%-524.80%-183.74%
Profit Margin
-160.86%-160.86%-173.69%-101.14%-524.80%-183.74%
FCF Margin
-182.98%-182.98%-182.04%-115.20%-446.19%-222.68%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PS Ratio
13.9325.177.183.3613.8614.17